104 related articles for article (PubMed ID: 8750799)
1. AQ-0145, a newly developed histamine H3 antagonist, decreased seizure susceptibility of electrically induced convulsions in mice.
Murakami K; Yokoyama H; Onodera K; Iinuma K; Watanabe T
Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():70-3. PubMed ID: 8750799
[TBL] [Abstract][Full Text] [Related]
2. Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice.
Yokoyama H; Onodera K; Iinuma K; Watanabe T
Eur J Pharmacol; 1993 Mar; 234(1):129-33. PubMed ID: 8386092
[TBL] [Abstract][Full Text] [Related]
3. Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice.
Yokoyama H; Onodera K; Maeyama K; Sakurai E; Iinuma K; Leurs R; Timmerman H; Watanabe T
Eur J Pharmacol; 1994 Jul; 260(1):23-8. PubMed ID: 7957622
[TBL] [Abstract][Full Text] [Related]
4. 2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice.
Yokoyama H; Onodera K; Iinuma K; Watanabe T
Pharmacol Biochem Behav; 1994 Mar; 47(3):503-7. PubMed ID: 7911577
[TBL] [Abstract][Full Text] [Related]
5. [Histamine and the convulsive threshold or effectiveness of antiepileptic drugs].
Ferenc R; Czuczwar SJ
Przegl Lek; 2008; 65(11):803-6. PubMed ID: 19205365
[TBL] [Abstract][Full Text] [Related]
6. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
[TBL] [Abstract][Full Text] [Related]
7. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
Swiader M; Wielosz M; Czuczwar SJ
Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
[TBL] [Abstract][Full Text] [Related]
8. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.
Huang ZL; Mochizuki T; Qu WM; Hong ZY; Watanabe T; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4687-92. PubMed ID: 16537376
[TBL] [Abstract][Full Text] [Related]
9. Morphine modulates the effects of histamine H1 and H3 receptors on seizure susceptibility in pentylenetetrazole-induced seizure model of mice.
Amini-Khoei H; Rahimi-Balaei M; Amiri S; Haj-Mirzaian A; Hassanipour M; Shirzadian A; Gooshe M; Alijanpour S; Mehr SE; Dehpour AR
Eur J Pharmacol; 2015 Dec; 769():43-7. PubMed ID: 26500121
[TBL] [Abstract][Full Text] [Related]
10. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
[TBL] [Abstract][Full Text] [Related]
11. Proconvulsive effects of histamine H1-antagonists on electrically-induced seizure in developing mice.
Yokoyama H; Onodera K; Iinuma K; Watanabe T
Psychopharmacology (Berl); 1993; 112(2-3):199-203. PubMed ID: 7871020
[TBL] [Abstract][Full Text] [Related]
12. [Possible roles of brain histamine H3 receptors and the pharmacology of its ligands].
Onodera K; Watanabe T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):87-102. PubMed ID: 7796325
[TBL] [Abstract][Full Text] [Related]
13. Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats.
Yokoyama H; Sato M; Iinuma K; Onodera K; Watanabe T
Neurosci Lett; 1996 Oct; 217(2-3):194-6. PubMed ID: 8916105
[TBL] [Abstract][Full Text] [Related]
14. Histaminergic neurons protect the developing hippocampus from kainic acid-induced neuronal damage in an organotypic coculture system.
Kukko-Lukjanov TK; Soini S; Taira T; Michelsen KA; Panula P; Holopainen IE
J Neurosci; 2006 Jan; 26(4):1088-97. PubMed ID: 16436594
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
[TBL] [Abstract][Full Text] [Related]
16. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
17. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
18. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
Krause M; Ligneau X; Stark H; Garbarg M; Schwartz JC; Schunack W
J Med Chem; 1998 Oct; 41(21):4171-6. PubMed ID: 9767653
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
[TBL] [Abstract][Full Text] [Related]
20. Effects of carnosine on amygdaloid-kindled seizures in Sprague-Dawley rats.
Jin CL; Yang LX; Wu XH; Li Q; Ding MP; Fan YY; Zhang WP; Luo JH; Chen Z
Neuroscience; 2005; 135(3):939-47. PubMed ID: 16125861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
